Liver transplantation (LT) for human immunodeficiency virus (HIV)-positive recipients with end-stage liver disease has become an accepted practice. However, because these patients are increasingly being recognized as prothrombotic, we reviewed their posttransplant thrombotic complications. Because m
Is Antithrombotic Prophylaxis Required After Liver Transplantation in HIV-Infected Recipients?
β Scribed by M. Gastaca; A. Valdivieso; M. Montejo; J. Bustamante; J. O. de Urbina
- Book ID
- 114806489
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 416 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1600-6135
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Liver transplantation is being evaluated as a therapeutic option for human immunodeficiency virus (HIV)-infected patients with end-stage liver disease, but experience is still scarce. We describe the outcome of 4 HIV-infected patients who underwent liver transplantation in our hospital between July
Cytomegalovirus (CMV) infections contracted after liver transplantation put patients at an increased risk of morbidity and mortality. We analyzed the effects of CMV infection by time of onset, mortality, and graft failure risk factors in liver recipients who were CMV donor-positive/recipient-positiv